EEG Characteristics in ECT
Trial Summary
What is the purpose of this trial?
This trial is testing a treatment for depression using electric shocks to the brain while patients are asleep with either ketamine or methohexital. The goal is to see how slow brain waves change during the treatment and if these changes can show how well the treatment is working. Ketamine has long been used as an alternative anesthetic for ECT and appears to initially enhance the benefits of ECT.
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive electroconvulsive therapy (ECT) with either ketamine or methohexital as the anesthesia induction agent, and dcEEG data is collected
Follow-up
Participants are monitored for cognitive performance and clinical efficacy of ECT
Treatment Details
Interventions
- Ketamine
- Methohexital
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor